Literature DB >> 8765522

Synthesis and quantitative structure-activity relationship of 17 beta-(hydrazonomethyl)-5 beta-androstane-3 beta,14 beta-diol derivatives that bind to Na+,K(+)-ATPase receptor.

L Quadri1, A Cerri, P Ferrari, E Folpini, M Mabilia, P Melloni.   

Abstract

A series of 17 beta-(hydrazonomethyl)-5 beta-androstane-3, beta,14 beta-diol derivatives was synthesized and evaluated in the displacement of [3H]ouabain binding from Na+,K(+)-ATPase. The data were explored with multiple linear regression and partial least-squares to find possible quantitatives structure-activity relationships. Good correlations were found between binding to the receptor and van der Waals volumes or molar refractivities of the 17 beta-hydrazonomethyl substituents and pKa values of the compounds. Equivalent results were obtained using the proton affinity (calculated using MOPAC) of the hydrazone residues instead of experimental pKa. As basicity or related electronic factors of the substituents explain a significant portion of the observed changes in the activity, an ion-pair interaction between a carboxylate residue of the enzyme and the protonated 17 beta-hydrazonomethyl group, as postulated by Thomas, plays an important role in the interaction of the ligand to the Na+,K(+)-ATPase receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8765522     DOI: 10.1021/jm950806n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Enhancing the potency of lithospermate B for inhibiting Na+/K+-ATPase activity by forming transition metal ion complexes.

Authors:  Nan-Hei Lin; Tse-Yu Chung; Feng-Yin Li; Hsin-An Chen; Jason T C Tzen
Journal:  Acta Pharmacol Sin       Date:  2013-05-20       Impact factor: 6.150

2.  Antiproliferative activity of cardenolides on cell line A549: structure-activity relationship analysis.

Authors:  Salvador Enrique Meneses-Sagrero; Luisa Alondra Rascón-Valenzuela; Rogerio Sotelo-Mundo; Wagner Vilegas; Carlos Velazquez; Juan Carlos García-Ramos; Ramón Enrique Robles-Zepeda
Journal:  Mol Divers       Date:  2020-07-05       Impact factor: 2.943

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.